🇺🇸 US

VRTX revenue, net income and debt history (Vertex Pharmaceuticals Inc / Ma)

Quick answer

Vertex Pharmaceuticals Inc / Ma (VRTX) reported revenue of $12.00B and net income of $3.95B for the fiscal year ended 2025-12-31, up 8.9% from $11.02B the year before, per its 10-K filed with the SEC on 2026-02-13.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Fiscal yearRevenueNet incomeLong-term debt
2025 (FY ending 2025-12-31)$12.00B$3.95B—
2024 (FY ending 2024-12-31)$11.02B-$535.6M—
2023 (FY ending 2023-12-31)$9.87B$3.62B—
2022 (FY ending 2022-12-31)$8.93B$3.32B—
2021 (FY ending 2021-12-31)$7.57B$2.34B—
2020 (FY ending 2020-12-31)$6.21B$2.71B—
2019 (FY ending 2019-12-31)$4.16B$1.18B—
2018 (FY ending 2018-12-31)$3.05B$2.10B—
2017 (FY ending 2017-12-31)$2.49B$263.5M—
2016 (FY ending 2016-12-31)$1.70B-$112.1M—

Related

Last updated 2026-10-16. Data only, not financial or tax advice.